VectivBio Holding AG
(NASDAQ GS: VECT)
Rigrodsky Law, P.A. is investigating VectivBio Holding AG (“VectivBio”) regarding possible breaches of fiduciary duties and other violations of law related to VectivBio’s agreement to be acquired by Ironwood Pharmaceuticals, Inc. Under the terms of the agreement, VectivBio shareholders will receive $17.00 per share in cash.